Health In Tech, Inc.
NASDAQ:HITSoftware - Application
+$0.00 today
- Market cap
- $50.13M
- Beta
- 2.94
- P/E (TTM)
- -75.2
- EPS (TTM)
- -$0.01
Volume 0.04M
Average 0.23M
HIT Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Health In Tech, Inc.NASDAQ: HIT
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue grows, but more slowly than its trailing trend
Q1 FY2026 cost of revenue of $4.26M rose 60.3% year over year, behind the +144.6% change in trailing-twelve-month cost of revenue. Sequentially, it rose 26.1% from the prior quarter. Over 3 fiscal years it compounded at +233.4% a year.
Context
- Cost of revenue amounted to 37.2% of revenue in FY2025, up 16.4 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +60.3% toward the trailing-twelve-month pace of +144.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 12.39M USD
- Year-over-year change
- +205.8%
- 3-year CAGR
- +233.4%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.39M | +205.8% |
| FY2024 | 2024-12-31 | 4.05M | +75.9% |
| FY2023 | 2023-12-31 | 2.3M | +589.4% |
| FY2022 | 2022-12-31 | 334.19K | — |
Cost of Revenue vs competitors
How HIT compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +144.6% is the highest of 8, against a peer median of +4.5%.
- Cost of revenue amounts to 41.1% of revenue for HIT, versus a peer median of 50.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
TEADTeads Holding Co. | LTM Mar 2026 | $850.07M USD | +17.1% | +2.9% | 66.4% |
| LTM Mar 2026 | $161.12M USD | -3.7% | -22.2% | 44.5% | |
| LTM Mar 2026 | $97.28M USD | -24.0% | -33.7% | 63.7% | |
| LTM Mar 2026 | $70.54M USD | +4.5% | +4.0% | 50.4% | |
| FY2025 | $15.53M USD | +91.0% | +72.0% | 90.9% | |
SVCOSilvaco Group, Inc. Common Stock | LTM Mar 2026 | $14.06M USD | +7.4% | +15.5% | 21.1% |
HITHealth In Tech, Inc. | LTM Mar 2026 | $13.99M USD | +144.6% | +233.4% | 41.1% |
LAWRRobot Consulting Co., Ltd. ADS | FY2025 | ¥3.94M JPY | -80.2% | -56.7% | 0.6% |
| Peer median (excluding HIT) | — | +4.5% | +2.9% | 50.4% | |
Competitors are the stored peer set for HIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 5.77M | 19.15M | 19.49M | 33.33M |
| Cost of Revenue | 334.19K | 2.3M | 4.05M | 12.39M |
| Gross Profit | 5.44M | 16.85M | 15.44M | 20.94M |
| Gross Margin | 94.2% | 88.0% | 79.2% | 62.8% |
| Research & Development | 794.62K | 2M | 2.81M | 1.57M |
| Selling, General & Admin | 4.44M | 11.46M | 11.64M | 17.84M |
| Operating Expenses | 5.23M | 13.46M | 14.45M | 19.41M |
| Depreciation & Amortization | 0 | 339.3K | 541.14K | 900.58K |
| EBITDA | 205.58K | 3.76M | 1.93M | 2.57M |
| EBITDA Margin | 3.6% | 19.6% | 9.9% | 7.7% |
| Operating Income | 205.58K | 3.38M | 989.9K | 1.53M |
| Operating Margin | 3.6% | 17.7% | 5.1% | 4.6% |
| Interest Income | 0 | 40.86K | 122.89K | 409.92K |
| Interest Expense | 4.57K | 2.05K | 495K | 0 |
| Other Income / Expenses | (4.57K) | 38.81K | (100.9K) | 145.73K |
| Income Before Tax | 201.01K | 3.42M | 889K | 1.67M |
| Pre-Tax Margin | 3.5% | 17.9% | 4.6% | 5.0% |
| Income Tax Expense | 121.27K | 945.24K | 218.52K | 395.33K |
| Net Income | 79.74K | 2.48M | 670.48K | 1.28M |
| Net Margin | 1.4% | 12.9% | 3.4% | 3.8% |
| EPS (Basic) | 0.00 | 0.05 | 0.01 | 0.02 |
| EPS (Diluted) | 0.00 | 0.05 | 0.01 | 0.02 |
| Weighted Avg Shares | 54.07M | 54.07M | 67.05M | 55.84M |
| Weighted Avg Shares (Diluted) | 54.07M | 54.07M | 53.66M | 57.74M |
Health In Tech, Inc.
NASDAQ:HIT
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.